vs
Aurinia Pharmaceuticals Inc.（AUPH）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
Aurinia Pharmaceuticals Inc.的季度营收约是REGIS CORP的1.4倍（$77.1M vs $57.1M），Aurinia Pharmaceuticals Inc.净利率更高（273.4% vs 0.8%，领先272.6%），Aurinia Pharmaceuticals Inc.同比增速更快（28.8% vs 22.3%），过去两年Aurinia Pharmaceuticals Inc.的营收复合增速更高（23.8% vs 7.8%）
Aurinia Pharmaceuticals是一家生物制药企业，专注于自身免疫疾病及肾脏疾病靶向疗法的研发与商业化，核心获批产品为用于治疗成人活动性狼疮性肾炎的Lupkynis，主要市场覆盖北美及欧洲地区。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
AUPH vs RGS — 直观对比
营收规模更大
AUPH
是对方的1.4倍
$57.1M
营收增速更快
AUPH
高出6.6%
22.3%
净利率更高
AUPH
高出272.6%
0.8%
两年增速更快
AUPH
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $77.1M | $57.1M |
| 净利润 | $210.8M | $456.0K |
| 毛利率 | 88.6% | — |
| 营业利润率 | 43.1% | 10.8% |
| 净利率 | 273.4% | 0.8% |
| 营收同比 | 28.8% | 22.3% |
| 净利润同比 | 14651.2% | -94.0% |
| 每股收益（稀释后） | $1.52 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AUPHRGS
| Q4 25 | $77.1M | $57.1M | ||
| Q3 25 | $73.5M | $59.0M | ||
| Q2 25 | $70.0M | $60.4M | ||
| Q1 25 | $62.5M | $57.0M | ||
| Q4 24 | $59.9M | $46.7M | ||
| Q3 24 | $67.8M | $46.1M | ||
| Q2 24 | $57.2M | $49.4M | ||
| Q1 24 | $50.3M | $49.2M |
净利润AUPHRGS
| Q4 25 | $210.8M | $456.0K | ||
| Q3 25 | $31.6M | $1.4M | ||
| Q2 25 | $21.5M | $116.5M | ||
| Q1 25 | $23.3M | $250.0K | ||
| Q4 24 | $1.4M | $7.6M | ||
| Q3 24 | $14.3M | $-853.0K | ||
| Q2 24 | $722.0K | $91.2M | ||
| Q1 24 | $-10.7M | $-2.3M |
毛利率AUPHRGS
| Q4 25 | 88.6% | — | ||
| Q3 25 | 88.9% | — | ||
| Q2 25 | 89.8% | — | ||
| Q1 25 | 86.3% | — | ||
| Q4 24 | 90.7% | — | ||
| Q3 24 | 91.1% | — | ||
| Q2 24 | 84.4% | — | ||
| Q1 24 | 84.6% | — |
营业利润率AUPHRGS
| Q4 25 | 43.1% | 10.8% | ||
| Q3 25 | 40.5% | 10.0% | ||
| Q2 25 | 28.7% | 12.1% | ||
| Q1 25 | 35.0% | 8.8% | ||
| Q4 24 | -2.8% | 11.8% | ||
| Q3 24 | 17.3% | 4.6% | ||
| Q2 24 | -2.6% | — | ||
| Q1 24 | -26.3% | 8.3% |
净利率AUPHRGS
| Q4 25 | 273.4% | 0.8% | ||
| Q3 25 | 42.9% | 2.3% | ||
| Q2 25 | 30.7% | 192.9% | ||
| Q1 25 | 37.4% | 0.4% | ||
| Q4 24 | 2.4% | 16.4% | ||
| Q3 24 | 21.2% | -1.9% | ||
| Q2 24 | 1.3% | 184.7% | ||
| Q1 24 | -21.4% | -4.7% |
每股收益（稀释后）AUPHRGS
| Q4 25 | $1.52 | $0.16 | ||
| Q3 25 | $0.23 | $0.49 | ||
| Q2 25 | $0.16 | $43.67 | ||
| Q1 25 | $0.16 | $0.08 | ||
| Q4 24 | $0.00 | $2.71 | ||
| Q3 24 | $0.10 | $-0.36 | ||
| Q2 24 | $0.01 | $38.40 | ||
| Q1 24 | $-0.07 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.2M | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | $581.3M | $188.7M |
| 总资产 | $751.6M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资AUPHRGS
| Q4 25 | $80.2M | $18.4M | ||
| Q3 25 | $72.9M | $16.6M | ||
| Q2 25 | $52.9M | $17.0M | ||
| Q1 25 | $66.1M | $13.3M | ||
| Q4 24 | $83.4M | $10.2M | ||
| Q3 24 | $36.6M | $6.3M | ||
| Q2 24 | $33.3M | $10.1M | ||
| Q1 24 | $63.9M | $5.9M |
总债务AUPHRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益AUPHRGS
| Q4 25 | $581.3M | $188.7M | ||
| Q3 25 | $365.8M | $187.6M | ||
| Q2 25 | $335.3M | $185.6M | ||
| Q1 25 | $350.2M | $68.6M | ||
| Q4 24 | $377.5M | $66.7M | ||
| Q3 24 | $388.0M | $56.4M | ||
| Q2 24 | $364.6M | $56.8M | ||
| Q1 24 | $359.5M | $-35.8M |
总资产AUPHRGS
| Q4 25 | $751.6M | $588.3M | ||
| Q3 25 | $527.5M | $592.1M | ||
| Q2 25 | $502.6M | $599.0M | ||
| Q1 25 | $504.9M | $511.2M | ||
| Q4 24 | $550.6M | $530.1M | ||
| Q3 24 | $549.4M | $508.9M | ||
| Q2 24 | $523.5M | $530.5M | ||
| Q1 24 | $516.6M | $543.7M |
负债/权益比AUPHRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.7M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | — | $891.0K |
| 自由现金流率自由现金流/营收 | — | 1.6% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | 0.22× | 3.65× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流AUPHRGS
| Q4 25 | $45.7M | $1.7M | ||
| Q3 25 | $44.4M | $2.3M | ||
| Q2 25 | $44.2M | $6.8M | ||
| Q1 25 | $1.3M | $6.2M | ||
| Q4 24 | $30.1M | $2.1M | ||
| Q3 24 | $17.0M | $-1.3M | ||
| Q2 24 | $15.8M | $5.1M | ||
| Q1 24 | $-18.6M | $-277.0K |
自由现金流AUPHRGS
| Q4 25 | — | $891.0K | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $-326.0K |
自由现金流率AUPHRGS
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | -3.0% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | — | -0.7% |
资本支出强度AUPHRGS
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
现金转化率AUPHRGS
| Q4 25 | 0.22× | 3.65× | ||
| Q3 25 | 1.41× | 1.68× | ||
| Q2 25 | 2.06× | 0.06× | ||
| Q1 25 | 0.06× | 24.80× | ||
| Q4 24 | 21.07× | 0.28× | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 21.94× | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AUPH
| Products | $74.2M | 96% |
| License Collaboration And Royalty Revenue | $2.9M | 4% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
